These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23145890)
1. The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women? Salloum RG; Jensen GA; Biddle AK J Womens Health (Larchmt); 2013 Jan; 22(1):19-25. PubMed ID: 23145890 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization. Xu WY; Wickizer TM; Jung JK BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422 [TBL] [Abstract][Full Text] [Related]
3. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Borràs JM; Guillen M; Sánchez V; Juncà S; Vicente R Eur J Cancer Prev; 1999 Oct; 8(5):427-34. PubMed ID: 10548398 [TBL] [Abstract][Full Text] [Related]
4. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Potosky AL; Breen N; Graubard BI; Parsons PE Med Care; 1998 Mar; 36(3):257-70. PubMed ID: 9520952 [TBL] [Abstract][Full Text] [Related]
5. Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in Medicare. Xu WY; Jung JK Health Serv Res; 2017 Oct; 52(5):1772-1793. PubMed ID: 27624875 [TBL] [Abstract][Full Text] [Related]
6. Evaluating the effectiveness of Medicare's preventive visits. Lesser LI J Womens Health (Larchmt); 2013 Jan; 22(1):5-6. PubMed ID: 23276187 [No Abstract] [Full Text] [Related]
7. U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries. Salloum RG; Kohler RE; Jensen GA; Sheridan SL; Carpenter WR; Biddle AK J Womens Health (Larchmt); 2014 Mar; 23(3):211-7. PubMed ID: 24195774 [TBL] [Abstract][Full Text] [Related]
8. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002. Nash D; Chan C; Horowitz D; Vlahov D J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096 [TBL] [Abstract][Full Text] [Related]
9. Association between health insurance coverage of office visit and cancer screening among women. Friedman C; Ahmed F; Franks A; Weatherup T; Manning M; Vance A; Thompson BL Med Care; 2002 Nov; 40(11):1060-7. PubMed ID: 12409851 [TBL] [Abstract][Full Text] [Related]
10. The effect of Medicare Advantage enrollment on mammographic screening. Hung A; Stuart B; Harris I Am J Manag Care; 2016 Feb; 22(2):e53-9. PubMed ID: 26881320 [TBL] [Abstract][Full Text] [Related]
11. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ostbye T; Greenberg GN; Taylor DH; Lee AM Ann Fam Med; 2003; 1(4):209-17. PubMed ID: 15055410 [TBL] [Abstract][Full Text] [Related]
12. Breast and cervical cancer screening in older women: the San Diego Medicare Preventive Health Project. Mayer JA; Slymen DJ; Drew JA; Wright BL; Elder JP; Williams SJ Prev Med; 1992 Jul; 21(4):395-404. PubMed ID: 1409483 [TBL] [Abstract][Full Text] [Related]
13. Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers. Xu X; Mann JR; McDermott SW; Deroche CB; Gustafson E; Hardin JW Ophthalmic Epidemiol; 2017 Jun; 24(3):168-173. PubMed ID: 27552166 [TBL] [Abstract][Full Text] [Related]
14. Preventive practices of cancer screening in women: comparison of estimates from ISA--Capital survey and the telephone-based Surveillance of Risk and Protective Factors for Chronic Diseases (VIGITEL--São Paulo). Segri NJ; Francisco PM; Alves MC; Barros MB; Cesar CL; Goldbaum M; Malta DC Rev Bras Epidemiol; 2011 Sep; 14 Suppl 1():31-43. PubMed ID: 22002140 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women. Sabatino SA; Thompson TD; Miller JW; Breen N; White MC; Breslau E; Shoemaker ML J Womens Health (Larchmt); 2019 Jul; 28(7):910-918. PubMed ID: 30265611 [No Abstract] [Full Text] [Related]
16. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population. Tailor TD; Tong BC; Gao J; Henderson LM; Choudhury KR; Rubin GD Chest; 2020 Nov; 158(5):2200-2210. PubMed ID: 32562612 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Medicare Annual Wellness Visits on Breast Cancer Screening and Diagnosis. Hamer MK; Bradley CJ; Lindrooth R; Perraillon MC Med Care; 2024 Aug; 62(8):530-537. PubMed ID: 38889206 [TBL] [Abstract][Full Text] [Related]
18. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009. Park MJ; Park EC; Choi KS; Jun JK; Lee HY BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with the utilization of mammographic screening in Greece. Naoum P; Skroumpelos A; Athanasakis K; Kyriopoulos J Eur J Cancer Prev; 2018 Jan; 27(1):13-19. PubMed ID: 27439007 [TBL] [Abstract][Full Text] [Related]
20. Effect of cost-sharing reductions on preventive service use among Medicare fee-for-service beneficiaries. Goodwin SM; Anderson GF Medicare Medicaid Res Rev; 2012; 2(1):. PubMed ID: 24800136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]